Methylmalonic acid is a more sensitive marker of functional B12 deficiency than serum B12 alone
53 , D886D900 (2025)
Carolyn Bramante, associate professor at the University of Minnesota Medical School
Pharmacotherapy Obesity pharmacotherapy has recently experienced a revolution with the advent of glucagon-like-peptide (GLP)-1 agonists (for example, semaglutide), and subsequently multi-incretin receptor agonists including dual agonists (for example, gastric inhibitory polypeptide (GIP) analogue and a GLP-1 receptor agonist, Tirzepatide) and triple agonists (for example, GLP-1, GIP, and glucagon receptor (GCGR), Retatrutide)
Related Stories Generic semaglutide could improve diabetes treatment affordability in Canada Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits GLP-1 receptor agonists may increase hair loss risk Considering the SELECT trial report, the experts indicated the beneficial effects of continuing semaglutide treatment, particularly in patients with cardiovascular disease, even if they do not undergo the recommended weight loss
Semaglyn Injection (3ml Cartridge with 10 Needle) is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight